Alpha 1-antitrypsin deficiency secondary prevention: Difference between revisions
Irfan Dotani (talk | contribs) No edit summary |
Mazia Fatima (talk | contribs) |
||
| Line 8: | Line 8: | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
Secondary prevention strategies following alpha1-antitrypsin deficiency (AATD) includes : | |||
The most effective secondary prevention strategy for alpha1-antitrypsin deficiency (AATD) patient is to avoid cigarette smoking. | |||
Smoking accelerates the progression of emphysema in severely deficient individuals by as much as 15 years when compared to their nonsmoking controls. | |||
==References== | ==References== | ||
Revision as of 12:35, 5 December 2017
|
Alpha 1-antitrypsin deficiency Microchapters |
|
Differentiating Alpha 1-antitrypsin deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Alpha 1-antitrypsin deficiency secondary prevention On the Web |
|
American Roentgen Ray Society Images of Alpha 1-antitrypsin deficiency secondary prevention |
|
Alpha 1-antitrypsin deficiency secondary prevention in the news |
|
Blogs on Alpha 1-antitrypsin deficiency secondary prevention |
|
Directions to Hospitals Treating Alpha 1-antitrypsin deficiency |
|
Risk calculators and risk factors for Alpha 1-antitrypsin deficiency secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Secondary Prevention
Secondary prevention strategies following alpha1-antitrypsin deficiency (AATD) includes :
The most effective secondary prevention strategy for alpha1-antitrypsin deficiency (AATD) patient is to avoid cigarette smoking.
Smoking accelerates the progression of emphysema in severely deficient individuals by as much as 15 years when compared to their nonsmoking controls.